Population Pharmacokinetics of Florfenicol in Crayfish ( Procambarus clarkii ) Based on the Sparse Sampling Method and a Nonlinear Mixed‐Effect Model
Journal of Veterinary Pharmacology and Therapeutics · 2025
DOI: 10.1111/jvp.70011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2025. Verfasst von Ning Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan, China. Hauptthemen laut MEDLINE: Thiamphenicol, Astacoidea, Anti-Bacterial Agents. Die Arbeit nennt 14 Literaturangaben. Gefördert von: Central Public-interest Scientific Institution Basal Research Fund, Chinese Academy of Fishery Sciences, National Natural Science Foundation of China, R & D Program of Hubei in Characteristic Freshwater Products Industry Chain.
Abstract (Originalsprache)
The present study was conducted to establish population pharmacokinetics (PPK) of florfenicol (FLO) in crayfish ( Procambarus clarkii ) after a single oral administration at a dose of 15 mg/kg at 25°C based on a nonlinear mixed effect model. The sparse sampling method was used to collect the blood samples. Thirty‐two crayfish were divided into four groups, and one group included four male crayfish and four female crayfish. One animal undertook three sampling time points. All samples were quantified using high‐performance liquid chromatography with an ultraviolet detector. The initial pharmacokinetic (PK) parameters were estimated by reference search and the calculation of a naïve pooled approach. The additive error model was selected using the tool of maximum likelihood model comparison. The covariate model included the two variations of body weight and sex. Through the addition and subtraction of parameters, weight and gender had no significant effect on the alterations of PK parameters. Afterward, the random effects were introduced in the model, which notably reduced the coefficient of variation. Finally, the calculated values of the absorption rate constant, apparent distribution volume, and total systemic clearance were estimated to be 1.93/h, 11.16 L/kg, and 2.35 L/h/kg, respectively. The secondary parameters of the elimination rate constant, elimination half‐life, and area under the concentration‐time curve were calculated to be 0.20/h, 3.47 h, and 6.38 h.mg/L, respectively. This study supported a concise method for conducting PK studies in crustacean animals that facilitated the development of PK methodology in aquaculture.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan, China.
- School of Chemical Engineering & Biotechnology, XingTai University, Xingtai, China.
- Agro-Environmental Protection Institute, Ministry of Agriculture and Rural Affairs, Tianjin, China.
ORCID-Profile: Ning Xu
Förderung
- Central Public-interest Scientific Institution Basal Research Fund, Chinese Academy of Fishery Sciences
- National Natural Science Foundation of China
- R & D Program of Hubei in Characteristic Freshwater Products Industry Chain
- National Key Research and Development Program of China
Zitieren
APA
Xu, N., Tian, J., Gong, B., Ding, Y., & Ai, X. (2025). Population Pharmacokinetics of Florfenicol in Crayfish ( Procambarus clarkii ) Based on the Sparse Sampling Method and a Nonlinear Mixed‐Effect Model. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.70011
Vancouver
Xu N, Tian J, Gong B, Ding Y, Ai X. Population Pharmacokinetics of Florfenicol in Crayfish ( Procambarus clarkii ) Based on the Sparse Sampling Method and a Nonlinear Mixed‐Effect Model. Journal of Veterinary Pharmacology and Therapeutics. 2025. doi:10.1111/jvp.70011
BibTeX
@article{Xu2025,
author = {Xu, Ning and Tian, Juan and Gong, Binbin and Ding, Yongzhen and Ai, Xiaohui},
title = {Population Pharmacokinetics of Florfenicol in Crayfish ( Procambarus clarkii ) Based on the Sparse Sampling Method and a Nonlinear Mixed‐Effect Model},
journal = {Journal of Veterinary Pharmacology and Therapeutics},
year = {2025},
doi = {10.1111/jvp.70011}
}
EUVIMED